For research teamsHelp me find a study
Back to all studies
Active Not RecruitingNCT06809595

MM120 Compared to Placebo for anxiety

This study is active but not recruiting in the United States, in France, in the United Kingdom, .... It is testing MM120 Compared to Placebo for anxiety.

AnxietyDrugFrom 18 Years to 74 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether MM120 may be useful for adults experiencing anxiety.

What would participation involve?

Participants may receive MM120, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Czechia, in France, and in Germany.

Who is it mainly for?

This study appears to be mainly for adults with anxiety.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: January 29, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
245
Sponsor
Definium Therapeutics US, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, United Kingdom, ...
Age range
From 18 Years to 74 Years
Official registry ID
NCT06809595
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06809595. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Czechia · 3 sites
  • A-shine s.r.o.
    Pilsen
    Site status: Not listed — confirm with the team
  • Institut Neuropsychiatricke Pece (INEP)
    Prague
    Site status: Not listed — confirm with the team
  • Psyon s.r.o.
    Prague
    Site status: Not listed — confirm with the team
France · 5 sites
  • Cabinet Dr.Desbonnet : Résidence Saint Michel
    Douai
    Site status: Not listed — confirm with the team
  • Hôpital Conception, CIC Centre, bat néphrologie 3eme étage
    Marseille
    Site status: Not listed — confirm with the team
  • CMME
    Paris
    Site status: Not listed — confirm with the team
  • GHU Paris Psychiatrie et Neurosciences
    Paris
    Site status: Not listed — confirm with the team
  • Centre Hospitalier du Rouvray
    Sotteville-lès-Rouen
    Site status: Not listed — confirm with the team
Germany · 4 sites
  • Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin Berlin
    Berlin
    Site status: Not listed — confirm with the team
  • OVID Clinic Berlin
    Berlin
    Site status: Not listed — confirm with the team
  • Central Institute of Mental Health
    Mannheim
    Site status: Not listed — confirm with the team
  • Klinik für Psychiatrie und Psychotherapie, Abt: Allgemeine Psychiatrie und Psychotherapie
    Tübingen
    Site status: Not listed — confirm with the team
Poland · 3 sites
  • Centrum Badan Klinicznych PI-House sp. z o.o.
    Gdansk
    Site status: Not listed — confirm with the team
  • Department of Psychiatry, UCK
    Gdansk
    Site status: Not listed — confirm with the team
  • Department of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of Lodz
    Lodz
    Site status: Not listed — confirm with the team
United Kingdom · 8 sites
  • Neuroclin Glasgow
    Glasgow
    Site status: Not listed — confirm with the team
  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, St. Nicholas Hospital
    Gosforth
    Site status: Not listed — confirm with the team
  • 4 Medical Clinical Solutions
    London
    Site status: Not listed — confirm with the team
  • Clerkenwell Health - Baker Street
    London
    Site status: Not listed — confirm with the team
  • Clerkenwell Health
    London
    Site status: Not listed — confirm with the team
  • South London and Maudsley NHS Foundation Trust of The Maudsley Hospital
    London
    Site status: Not listed — confirm with the team
  • 4 Medical Clinical Solutions
    Manchester
    Site status: Not listed — confirm with the team
  • St George's Community Health Centre
    Sheffield
    Site status: Not listed — confirm with the team
United States · 13 sites
  • Preferred Research Partners, Inc.
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Psychedelic Science Institute
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • West Los Angeles VA Medical Center
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Bradenton Research Center, Inc.
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solutions, Inc
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Sheppard Pratt Health System
    Towson, Maryland
    Site status: Not listed — confirm with the team
  • Adams Clinical Boston
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Princeton Medical Institute
    Princeton, New Jersey
    Site status: Not listed — confirm with the team
  • University of Cincinnati Psychiatry- Anxiety Disorders Research Program
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Neuro-Behavioral Clinical Research, Inc.
    North Canton, Ohio
    Site status: Not listed — confirm with the team
  • Austin Clinical Trial Partners
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Core Clinical Research
    Everett, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, DT120. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with anxiety; age range: From 18 Years to 74 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Definium Therapeutics US, Inc., which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.